Genetic polymorphisms in drug-metabolizing enzymes further complicate toxicity profiles
the cost isn't covered in all patients insurance, so a lot of the patients cannot avail of it because of the budget
Results showed that under 24% of GLP-1 users needed ER care, compared with more than 26% of those on topiramate
Without strict controls, the risk of contamination or adulteration increases, which undermines both safety and effectiveness
However, patients currently on weekly GLP-1 medications should remain aware of the following side effects that may improve or in some cases intensify with dose or frequency changes: Nausea, vomiting, or diarrhea most common during dose increases Constipation particularly at higher doses Injection-site reactions (redness, bruising, lumps) manageable with rotating injection sites Fatigue during dose escalation Do not change your GLP-1 dose, injection frequency, or brand without speaking with your prescribing provider first